Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19738339rdf:typepubmed:Citationlld:pubmed
pubmed-article:19738339lifeskim:mentionsumls-concept:C0024530lld:lifeskim
pubmed-article:19738339lifeskim:mentionsumls-concept:C0032961lld:lifeskim
pubmed-article:19738339lifeskim:mentionsumls-concept:C0019994lld:lifeskim
pubmed-article:19738339lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:19738339lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:19738339lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:19738339lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:19738339lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:19738339lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:19738339lifeskim:mentionsumls-concept:C0206034lld:lifeskim
pubmed-article:19738339lifeskim:mentionsumls-concept:C0205468lld:lifeskim
pubmed-article:19738339lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:19738339lifeskim:mentionsumls-concept:C0041573lld:lifeskim
pubmed-article:19738339lifeskim:mentionsumls-concept:C0936150lld:lifeskim
pubmed-article:19738339lifeskim:mentionsumls-concept:C1957158lld:lifeskim
pubmed-article:19738339pubmed:issue2lld:pubmed
pubmed-article:19738339pubmed:dateCreated2009-9-9lld:pubmed
pubmed-article:19738339pubmed:abstractTextMalaria infection during pregnancy is a major public health problem. Due to increasing resistance to Chloroquine and Sulphadoxine/Pyrimethamine, the Ugandan national policy on malaria treatment was changed in 2005 to Artemisinin-based combination therapy (ACT) as the first-line treatment for uncomplicated malaria. The policy recommends assessment of safety and efficacy of alternative drugs for treatment of uncomplicated malaria. We compared the efficacy and safety of Artemether-Lumefantrine (Coartem) and Chlorproguanil-Dapsone (Lapdap) in the management of uncomplicated malaria in pregnancy.lld:pubmed
pubmed-article:19738339pubmed:languageenglld:pubmed
pubmed-article:19738339pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19738339pubmed:citationSubsetIMlld:pubmed
pubmed-article:19738339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19738339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19738339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19738339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19738339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19738339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19738339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19738339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19738339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19738339pubmed:statusMEDLINElld:pubmed
pubmed-article:19738339pubmed:issn1972-2680lld:pubmed
pubmed-article:19738339pubmed:authorpubmed-author:NdeeziGraceGlld:pubmed
pubmed-article:19738339pubmed:authorpubmed-author:KayeDaniel...lld:pubmed
pubmed-article:19738339pubmed:authorpubmed-author:NshemerirweRu...lld:pubmed
pubmed-article:19738339pubmed:authorpubmed-author:MutyabaTwaha...lld:pubmed
pubmed-article:19738339pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19738339pubmed:volume2lld:pubmed
pubmed-article:19738339pubmed:ownerNLMlld:pubmed
pubmed-article:19738339pubmed:authorsCompleteYlld:pubmed
pubmed-article:19738339pubmed:pagination135-9lld:pubmed
pubmed-article:19738339pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:meshHeadingpubmed-meshheading:19738339...lld:pubmed
pubmed-article:19738339pubmed:year2008lld:pubmed
pubmed-article:19738339pubmed:articleTitleA randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda.lld:pubmed
pubmed-article:19738339pubmed:affiliationDepartment of Obstetrics and Gynecology, Makerere University Medical School, PO Box 7072, Kampala, Uganda. dankkaye@yahoo.comlld:pubmed
pubmed-article:19738339pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19738339pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:19738339pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed